We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$462M
AUM Growth
+$25.4M
Cap. Flow
-$4.16M
Cap. Flow %
-0.9%
Top 10 Hldgs %
73.54%
Holding
81
New
6
Increased
12
Reduced
43
Closed
5

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$4.72M
2
GILD icon
Gilead Sciences
GILD
+$1.75M
3
APA icon
APA Corp
APA
+$1.18M
4
NAT icon
Nordic American Tanker
NAT
+$870K
5
WPP icon
WPP
WPP
+$783K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$2.73M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.38M
3
GSK icon
GSK
GSK
+$1.6M
4
USG
Usg
USG
+$1.52M
5
BBBY
Bed Bath & Beyond Inc
BBBY
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 37.8%
2 Energy 19.32%
3 Healthcare 11.98%
4 Technology 9.77%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
26
APA Corp
APA
$14.6B
$2.55M 0.55%
60,455
+28,120
+87% +$1.18M
CSCO icon
27
Cisco
CSCO
$441B
$2.52M 0.55%
65,935
-120
-0.2% -$4.29K
AMGN icon
28
Amgen
AMGN
$239B
$2.5M 0.54%
14,385
+328
+2% +$58K
GSK icon
29
GSK
GSK
$103B
$2.41M 0.52%
54,420
-34,708
-39% -$1.6M
LLY icon
30
Eli Lilly
LLY
$1.06T
$2.28M 0.49%
27,015
LOW icon
31
Lowe's Companies
LOW
$119B
$2.13M 0.46%
22,904
-350
-2% -$28.9K
PFE icon
32
Pfizer
PFE
$162B
$2.12M 0.46%
61,541
+1,518
+3% +$51.8K
GE icon
33
GE Aerospace
GE
$367B
$2.03M 0.44%
24,287
+6,635
+38% +$633K
NAT icon
34
Nordic American Tanker
NAT
$1.37B
$1.79M 0.39%
727,750
+210,225
+41% +$870K
SU icon
35
Suncor Energy
SU
$77.1B
$1.73M 0.37%
47,020
-3,300
-7% -$115K
BIIB icon
36
Biogen
BIIB
$32.7B
$1.43M 0.31%
4,490
-100
-2% -$32.1K
AMBA icon
37
Ambarella
AMBA
$3.05B
$1.36M 0.29%
23,175
-3,370
-13% -$187K
JPM icon
38
JPMorgan Chase
JPM
$950B
$1.3M 0.28%
12,186
-350
-3% -$35.4K
CVX icon
39
Chevron
CVX
$394B
$1.28M 0.28%
10,249
MTB icon
40
M&T Bank
MTB
$34.9B
$1.26M 0.27%
7,350
-200
-3% -$33.2K
HON icon
41
Honeywell
HON
$69.5B
$1.25M 0.27%
8,994
-111
-1% -$14.9K
WPP icon
42
WPP
WPP
$5.6B
$1.22M 0.26%
13,465
+8,840
+191% +$783K
VIVO
43
DELISTED
Meridian Bioscience Inc
VIVO
$1.17M 0.25%
83,610
+11,275
+16% +$165K
CHK
44
DELISTED
Chesapeake Energy Corporation
CHK
$971K 0.21%
1,225
-508
-29% -$396K
ROKU icon
45
Roku
ROKU
$23.6B
$941K 0.2%
+18,165
New +$626K
GHL
46
DELISTED
Greenhill & Co., Inc.
GHL
$907K 0.2%
46,500
-16,425
-26% -$306K
PG icon
47
Procter & Gamble
PG
$337B
$883K 0.19%
9,614
AAPL icon
48
Apple
AAPL
$4.56T
$796K 0.17%
18,804
-400
-2% -$16.7K
BB icon
49
BlackBerry
BB
$4.51B
$728K 0.16%
65,205
-2,350
-3% -$25.6K
ZBH icon
50
Zimmer Biomet
ZBH
$19.3B
$637K 0.14%
5,433

Similar funds

Greylin Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Greylin Investment Management held 81 positions worth $462M, up 5.8% from $437M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Greylin Investment Management's Q4 2017 filing shows 6 new, 12 increased, 43 reduced and 5 closed positions. Its largest new stake was SLB Ltd: 72,910 shares worth $4.91M. The largest sale was IBM, an estimated $2.73M.

By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 38% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q4 2017 buy was SLB Ltd: 72,910 shares worth $4.91M.
  • Greylin Investment Management added most to Gilead Sciences in Q4 2017, an estimated $1.75M increase.
  • Greylin Investment Management's biggest Q4 2017 reduction was IBM, cutting an estimated $2.73M.
  • Greylin Investment Management fully exited Walmart Inc in Q4 2017, selling an estimated $446K.
  • Greylin Investment Management's ten largest holdings make up 74% of its $462M portfolio in Q4 2017.
  • Greylin Investment Management opened 6 new positions and closed 5 in Q4 2017.
  • Greylin Investment Management's portfolio value rose 5.8% quarter-over-quarter to $462M.

Based on Greylin Investment Management's 13F filing for Q4 2017, filed 16 Jan 2018.